Coy F. Blevins

Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.

Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA.

Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA.

The Foundry LLC provides investment services to medical device companies. It includes the inventor partners of business development, product development and prototyping, market analysis and development, human resources and recruitment and intellectual property enterprise. The company was founded by Allan R Will and Henry A. Plain, Jr. in 1998 and is headquartered in Menlo Park, CA.

Morgenthaler Management Corp (Morgenthaler Management) is a venture capital and private equity firm founded in 1968 by David Morgenthaler. The firm is headquartered in Portola Valley, California.

Relievant Medsystems, Inc. develops treatment and technologies for chronic back pain. Its Intracept System solution is a minimally invasive procedure that uses radiofrequency energy delivered into the vertebral body of the spine to ablate the basivertebral nerve. Relievant Medsystems was founded by James C. Peacock, Jeffrey Charles Lotz, and Rex Peters in 2004 and is headquartered in Redwood City, CA.

The National Association of Corporate Directors is a non-profit organization that provides essential resources to help directors strengthen board leadership. The American company was founded by Maryann Bruce and the CEO is Peter R. Gleason.

Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.

Kinetikos Medical, Inc. develops and manufactures orthopedic implants and surgical devices. It products helps to correct debilitating flatfoot for both pediatric and adult patients. The company's products are used for small bone and joint procedures involving the foot, ankle, hand, wrist, and elbow. It sells products through 45 independent sales agencies in the United States. Kinetikos Medical was founded in 1992 and is located in Carlsbad, CA.

Part of Centene Corp., Bridgeway Plan for Health is an American company that provides health insurance services. The company is located in the US. Bridgeway Plan for Health was acquired by QualMed, Inc., a subsidiary of Centene Corp. from California Pacific Health on May 18, 1992 for $24.40 million.

Miramar Technologies, Inc. develops and provides medical devices for dermatologic medical conditions. It specializes in microwave energy positioned to be adopted for dermatologic conditions. The company was founded by Henry A. Plain Jr., Mark E. Deem and Steven Kim in 2006 and is headquartered in Half Moon Bay, CA.

Earlens Corp. develops medical devices. It offers EarLens Contact Hearing Device that uses light to transmit sound. Its earlens contact hearing device two components: a tympanic membrane transducer, which is nonsurgically placed deep in the ear canal on the eardrum, and a light-based behind-the-ear sound processor placed at the base of the ear canal. The company was founded in 1999 by Rodney C. Perkins and is headquartered in Menlo Park, CA.

Part of Medtronic Plc, Progressive Angioplasty Systems, Inc. is a company that makes and develops stents and stent technologies. The company is based in Menlo Park, CA. The company was founded by Frank Litvak, Frank Litvack. Progressive Angioplasty Systems was acquired by United States Surgical Corp. on September 23, 1997 for $150 million.

Hotspur Technologies, Inc. manufactures medical devices and supplies for the dialysis treatment. The company was founded by James Howard Dreher, Jeffrey A. Krolik and Fred Khosravi in 2008 and is headquartered in Wayne, PA.

Imperative Care, Inc. is a healthcare technology company, which provides solutions to solve problems in stroke. It focuses on medical technology designed to expedite and improve the effectiveness of treatment, giving patients a chance for optimal recovery. The company is headquartered in Campbell, CA.

SetPoint Medical Corp. operates as a biomedical technology company, which engages in the development of therapies for patients with inflammatory autoimmune diseases such as rheumatoid arthritis and Crohn?s disease. The company was founded by Kevin J. Tracey, Shaw H. Warren, and James W. Broderick in 2006 and is headquartered in Santa Clarita, CA.

Transcend, Inc. provides training, consulting, and investigation services. The private company is based in Honolulu, HI. Plain. The company was founded by Henry A.

Moximed, Inc. develops minimally invasive, joint sparing solutions for patients with knee osteoarthritis. Its Osteoarthritis treatment can minimize joint pain, restore normal activity levels, and slow down disease progression. The company was founded by Anton G. Clifford in 2006 and is headquartered in Hayward, CA.

Qlt Plug Delivery, Inc. provides ocular punctual plug drug delivery system. Its product is used in the treatment of glaucoma. The company was founded by Henry A. Plain Jr. and is headquartered in Menlo Park, CA.

ForSight Labs LLC operates as an ophthalmic technology incubator. It focuses on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients. The company was founded by Eugene de Juan, Hanson S. Gifford and Henry A. Plain in 2005 and is headquartered in Menlo Park, CA.

Claret Medical, Inc. develops a cerebral protection technology designed to protect patients from the risk of stroke during left heart procedures and vascular interventions. It focuses on addressing the problem of stroke during transcatheter aortic valve replacement (TAVR), a significant unmet clinical need. The company was founded by Farhad Khosravi and Randy Lashinski in 2009 and is headquartered in Santa Rosa, CA.

LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California.

Nuvaira, Inc. develops medical devices for treating lung diseases. It works on a novel catheter-based system that has the potential to improve lung function, exercise capacity and quality of life for patients with chronic obstructive pulmonary disease. The company was founded by Steven Dimmer and Martin L. Mayse in 2008 and is headquartered in Plymouth, MN.

Twelve, Inc. is a holding company, which engages in the operation as an investment fund for a medical device incubator. It specializes on funding and developing medical device inventions. The company focuses on medical and biotech ventures. The company was founded in 2009 and is headquartered in Redwood City, CA.

Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.

Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.